opal-hiv-gag(c)
Vaccineexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2010 (NCT01123915)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- opal-hiv-gag(c)
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01123915 | Phase 1 | May 1, 2010 | Medicines Development for Global Health, Phillip T. and Susan M. Ragon Foundation, St Stephens Aids Trust, University of London |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Medicines Development for Global Health | For profit | 1 | 1 | 1 | 2010 |
| Phillip T. and Susan M. Ragon Foundation | Academic/Hospital | 1 | 0 | 1 | 2010 |
| St Stephens Aids Trust | Academic/Hospital | 1 | 0 | 1 | 2010 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2010 |
4 organizations
Page 1 / 1